bullish
The Truth of China Medical Insurance Fund - Time to Clarify Misunderstandings with Investors
Xinyao has highlighted this Insight as a Top Pick
281 Views31 May 2023 08:55
It's time to clarify misunderstandings about China medical insurance fund. We analyzed problems such as fund balance, payment situation, impact on industry scale, drug market outlook under fee control
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 6-minute read)
Discussions
(Paid Plans Only)
Top 5%
Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)
- China Healthcare Weekly (Jun.23) - National TCM VBP Results, CDE Changes Game Rule, Hua Medicine25 Jun 2023
- China Healthcare Weekly (Jun.16)- 9th National VBP Update, “Noise” of Consumption Upgrading, ChatGPT18 Jun 2023
- The Cyclicality of China Healthcare - Policy Environment, the Industry, and Investment Opportunities13 Jun 2023
- The Truth of China Medical Insurance Fund - Time to Clarify Misunderstandings with Investors31 May 2023
- BeiGene (6160.HK/BGNE.US) 23Q1 - Qualitative Changes Are Taking Place08 May 2023
- Sinopharm Group Co (1099.HK) - Double-Digit Growth Is Expected in 2023; Margins Have Room to Improve19 Apr 2023
- China Traditional Chinese Medicine (TCM) Industry - TCM Is Becoming Indispensable in the Portfolio30 Mar 2023
x